Assembly Biosciences, Inc. (ASMB) Financials
ASMB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 51.6 million | 9.9 million |
| 2023-06-30 | 66.6 million | 11.6 million |
| 2023-03-31 | 83.1 million | 12.8 million |
| 2022-12-31 | 101.8 million | 19.1 million |
ASMB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -14.0 million | 1.1 million |
| 2023-06-30 | -13.7 million | 1.2 million |
| 2023-03-31 | -23.4 million | 1.8 million |
| 2022-12-31 | -19.4 million | 2.0 million |
ASMB Net Income
No data available :(
ASMB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 46.2 million | - | 919000 |
| 2023-06-30 | 59.8 million | - | 1.8 million |
| 2023-03-31 | 73.0 million | - | 2.6 million |
| 2022-12-31 | 91.6 million | - | 3.5 million |
ASMB Shares Outstanding
ASMB Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 136000 | 10.8 million | 4.2 million | - |
| 2023-06-30 | 48000 | 12.5 million | 5.0 million | - |
| 2023-03-31 | 48000 | 14.5 million | 5.0 million | - |
| 2022-12-31 | 102000 | 16.9 million | 6.1 million | - |
ASMB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 116000 |
| 2023-06-30 | - | 126000 |
| 2023-03-31 | - | 124000 |
| 2022-12-31 | - | 124000 |
ASMB
Price: $13.15
52 week price:
Payout Ratio Range:
Earnings Per Share: -13.38 USD
P/E Ratio: -0.70
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 311844
Ebitda: -12.4 millionMarket Capitalization: 80.3 million